Women's Health Ultrasound

40-week-old male with a prenatally diagnosed abnormality on screening ultrasound. What is the diagnosis?

Known as the "Swiss Army knife" of healthcare, point-of-care ultrasound—or POCUS—has come a long way.

Feminizing hormone therapy may increase the risk of breast cancer in transgender women, a growing body of research suggests, underscoring a need for health care providers to understand the risks, breast imaging features, and health care needs of this demographic.

Including a DNA-methylation analysis could improve early diagnosis for BI-RADS 4 patients.

Non-invasive test misses more than four times the number of endometrial cancer cases in Black women than with white counterparts.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

No difference was seen between women who were screened yearly and those who did not undergo annual exams.

Classification leads to fewer missed breast cancers.

Here's what to expect this week on Diagnostic Imaging.

Patients indicated breast imaging radiologists expressed more empathy over the diagnosis and had more understanding of their scans than other providers.

Although these tests are controversial, they are highly effective in identifying lumps that lead to breast cancer diagnoses.

After a decade, roughly 75 percent of women with dense breasts seen in one department now undergo screening whole-breast ultrasound as a supplemental imaging service.

Algorithms outperformed providers in accurate, quick detection and classification.

Experts at ECR 2021 offer their top three tips for a variety of breast imaging techniques.

For women with dense breasts, automated breast ultrasound offers advantages over supplemental screening with hand-held ultrasound.

The approach, based on ACR guidance, is intended to promote vaccine use while reducing patient anxiety and unnecessary imaging.

Here's what to expect this week on Diagnostic Imaging.

Female breast cancer diagnosis is now the most common cancer diagnosis globally, largely affecting women in transitioning countries.

With more axillary adenopathies likely to present on breast imaging, Society of Breast Imaging experts offer guidance for best management during the pandemic.

Here's what to expect this week on Diagnostic Imaging.

COVID-19 Vaccine Adenopathies Mimic Breast Malignancies; Appendicitis, CT Exposure and Increased Cancer Risk; and MRI AI Tool for Prostate Cancer Recurrence Prediction

Swollen lymph nodes visualized on mammography and ultrasound appear days post-vaccination and could be mistaken for malignancies.

Seno’s Imagio® breast imaging system can help providers distinguish, in real-time, between benign and malignant breast lesions.

The pandemic’s impact on sonographers was largely a boomerang effect, but some struggles remain.

While the pandemic raged, work continued to advance the development of AI tools with breast imaging services.